Gene Therapy Development 2024

13 - 14 June 2024 | London, UK

Join leaders at the forefront of gene therapy development, offering insights on navigating the latest advancements and challenges in gene therapy production.

Presentation Speaker

Explore Gene Therapy Development 2024: Unlocking Future Insights in Gene Therapy Development Research

The 3rd Annual Gene Therapy Development Congress unites leading experts working in gene therapy development to provide a comprehensive journey through the latest advances and challenges, with the aim of accelerating gene therapy production.

3rd Annual Gene Therapy Development Congress

Gain an end-to-end outlook on the entire journey of gene therapy development, with 5 tracks exploring the discovery, clinical trial, manufacturing, and commercialisation of gene therapies.

Tackle the latest challenges in our interactive sessions featuring panel discussions and roundtables, addressing pressing issues such as vector design, gene engineering, preparing for regulatory changes, and more

Benefit from real-world case studies presented by industry experts, including insights into how to navigate regulatory submission, as well as operationalising clinical trials

Acquire practical solutions to overcome obstacles in the development and production of gene therapies, with opportunities to meet with and hear from vendor companies

Agenda at a Glance

  • Day One, Track 1: Vector Development
  • Day One, Track 2: Gene Therapy Manufacturing & Supply Chain 
  • Day One, Track 3: Pre-clinical and Clinical Therapeutic Development
  • Day Two, Track 1: Gene Therapy Analytics
  • Day Two, Track 2: Emerging Targets and Gene Editing Tools and Strategies

What to Expect


leading pharma, biotech, & academic delegates

hours of presentations, discussions & interactive content
hours of networking breaks, including speed networking & refreshments
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 45 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

Gene Therapy Development 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Alba Guijarro Belmar
Head of Vector Development,
Sania Therapeutics
Avencia Sanchez-Mejias
CEO and Co-Founder,
Integra Therapeutics
Claire Kerridge
Head of Gene Therapy,
Nathalie Cartier-Lacave
Vice President Neurobiology,
Nuno Barata
Global Medical Director,
Novartis Gene Therapies
Victor Ferrero
Associate Director, Global Product Strategy,

All Speakers

Alberto del Rio Espinola
GentiBio Inc
Alexander Baker
Principal Scientist,
Accession Therapeutics
Alexis Behra
Pharmaceutical CMC Development Manager,
Breech Conrad Odu
Merck Life Sciences
Charlotte Smerdon
Senior Director, Clinical Operations,
Purespring Therapeutics
Claudio Mussolino
Group Leader,
Medical Center - University of Freiburg
Dina Du
Senior Scientist,
Elina Hessels
Associate Director Analytical Platforms,
Ellina Allais
Regulatory Affairs Senior Director,
Cellectis S.A.
Eugenio Macchiarulo
Director of PD/MSAT,
Barinthus Biotherapeutics
Giandomenico Turchiano
Associate Director, Gene Editing Safety,
Isabelle Richard
Director of Research,
James Norton
Director Analytical Development,
Jane Kinghorn
Director, Translational Research Office,
University College London
Johnson Varghese
VP, Head of Analytical Research and Development,
Beam Therapeutics
Julia Berretta
Khalid Saeed
Senior scientist,
Koval Smith
Senior Manager DS/DP MSAT,
Orchard Therapeutics
Laurence Guianvarc'h
Head of Upstream & Downstream Process Development,
Nantes University
Leopold Parts
Group Leader,
Wellcome Sanger Institute
Lilian Hook
Director Cell, Apheresis and Gene Therapies,
NHS Blood and Transplant
Marcin Dembek
Senior Scientist,
Michel Degueldre
Lead GT Biophysical Sciences,
Nathalie Uzcategui
Senior Scientist,
Hansa BioPharma
Nina Kotsopoulou
AAVantgarde Bio
Otmane Boussif
Chief Technology Officer,
Anjarium Biosciences
Pamela Whalley
Associate Director CMC,
Patricia Lareo
Value Chain Capability Lead Gene Therapy,
Paul Carter
Senior Director MSAT,
Quell Therapeutics
Peter Pechan
Head of Vector Biology,
Richard Yu-Tsan Liu
Project Lead,
Rodolphe Clerval
Chief Executive Officer,
Coave Therapeutics
Senior Representative
Simon Eaglestone
Director, Program Management,
Vahap Aydogan
QA Expert Cell and Gene Therapy,
Victor Dillard
VP, Strategy & Operations,
Resolution Therapeutics
Vinciane De Cupere
Technical Lead Gene Therapy,

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.

Putting Menopause on Hold: Could Ovarian Cryopreservation Prevent Menopause?

Ovarian cryopreservation could prolong fertility, paving the way for a breakthrough in women’s reproductive freedom

Preserving Life's Potential: methods and conditions of cryopreservation

Cryopreservation is a key technology in medicine, biotechnology, and conservation, enabling the preservation of biological materials at ultra-low temperatures for future use. It supports medical treatments, scientific research, and species conservation by maintaining the genetic integrity of cells, tissues, and organs. Cell & Gene by Oxford Global explores its mechanisms, methodologies, applications, and the future directions this essential technology is headed towards.

Plan Your Visit

ILEC Conference Centre
47 Lillie Rd London SW6 1UD United Kingdom

By Underground

Sitting at the edge of zone 1, West Brompton and Earls Court stations are both within walking distance giving easy access to all central districts of London and Heathrow Airport. Transport for London tube map.

By Car

ILEC is a quarter of a mile (400m) from the A4, providing easy access to the M4, M5 and M40.

By Air

Heathrow (LHR): 21 km - Approximately 30 minutes in light traffic. You can also reach the airport directly by London Underground, on the Piccadilly line. Gatwick (LGW): 45 Km - Approximately an hour in light traffic. It is 40 minutes by train from West Brompton station via Clapham Junction. Direct shuttle available with Easy Bus. London City (LCY): 21 km - Approximately 45 minutes in light traffic.


There is a car park adjacent to ILEC with 140 parking bays. The parking is NOT managed by ILEC so spaces cannot be reserved and may become full during busy events. Guests and delegates can benefit from preferential parking rates as follows: Up to 2 hours £7 Up to 4 hours £11 Up to 6 hours £14 Up to 9 hours £16 (£21 for non-residents) Up to 12 hours £20 (£26 for non-residents) Up to 24 hours (overnight) £26

Oxford Global have secured a number of bedrooms at Novotel London West at a reduced rate:


Wednesday 12th June 2024 – £176, breakfast included

Thursday 13th June 2024 – £176, breakfast included


Should you wish to book a room, please email The final cut-off date to book bedrooms is Monday 29th April 2024 – any bookings after this date are subject to availability and rates. Please note that any cancellations within 14 days prior to arrival are subject to cancellation charges.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Gene Therapy Development 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch